Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · IEX Real-Time Price · USD
0.950
+0.020 (2.16%)
At close: Mar 28, 2024, 4:00 PM
0.990
+0.040 (4.21%)
After-hours: Mar 28, 2024, 4:12 PM EDT

Cytosorbents Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2006
Net Income
-28.51-32.81-24.56-7.84-19.27-17.21-8.8-11.76-9.48-18.59
Upgrade
Depreciation & Amortization
2.031.131.130.660.580.390.220.160.110.07
Upgrade
Share-Based Compensation
3.73.86.24.712.845.394.013.190.380.7
Upgrade
Other Operating Activities
1.12-0.353.22-3.14-0.910.6-2.221.68-0.072.28
Upgrade
Operating Cash Flow
-21.66-28.23-14.01-5.61-16.76-10.84-6.46-6.73-9.05-6.28
Upgrade
Capital Expenditures
-0.54-6.09-3.64-0.71-0.7-0.67-0.99-0.14-0.4-0.15
Upgrade
Change in Investments
00000002.19-0.25-1.94
Upgrade
Other Investing Activities
-0.4-0.37-0.64-0.97-0.82-0.85-0.69-0.45-0.24-0.21
Upgrade
Investing Cash Flow
-0.94-6.46-4.28-1.68-1.52-1.52-1.681.6-0.89-2.31
Upgrade
Share Issuance / Repurchase
14.47-0.040.7281.723.1817.6115.120.1811.6410.02
Upgrade
Debt Issued / Paid
050-15.38505500
Upgrade
Other Financing Activities
-----0-0.15-0-0.12--
Upgrade
Financing Cash Flow
14.474.960.7266.358.1817.4720.125.0611.6410.02
Upgrade
Exchange Rate Effect
-0.1-0.26-0.020.13-0.04-0.060.09-00.01-0
Upgrade
Net Cash Flow
-8.22-29.99-17.659.19-10.145.0512.08-0.071.711.42
Upgrade
Free Cash Flow
-22.19-34.32-17.65-6.32-17.46-11.51-7.45-6.87-9.45-6.43
Upgrade
Free Cash Flow Margin
-61.06%-98.94%-40.88%-15.42%-69.97%-51.15%-49.18%-72.12%-197.25%-156.06%
Upgrade
Free Cash Flow Per Share
-0.50-0.79-0.41-0.16-0.54-0.38-0.27-0.27-0.38-0.45
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).